- Home
- FGEN vs WVVI Comparison
FGEN vs WVVI Comparison
Compare FGEN & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- WVVI
- Stock Information
- Founded
- FGEN 1993
- WVVI 1983
- Country
- FGEN United States
- WVVI United States
- Employees
- FGEN N/A
- WVVI N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- FGEN Health Care
- WVVI Consumer Staples
- Exchange
- FGEN Nasdaq
- WVVI Nasdaq
- Market Cap
- FGEN 34.5M
- WVVI 29.8M
- IPO Year
- FGEN 2014
- WVVI N/A
- Fundamental
- Price
- FGEN $0.71
- WVVI $6.09
- Analyst Decision
- FGEN Strong Buy
- WVVI
- Analyst Count
- FGEN 1
- WVVI 0
- Target Price
- FGEN $10.00
- WVVI N/A
- AVG Volume (30 Days)
- FGEN 7.2M
- WVVI 9.8K
- Earning Date
- FGEN 03-04-2025
- WVVI 03-25-2025
- Dividend Yield
- FGEN N/A
- WVVI N/A
- EPS Growth
- FGEN N/A
- WVVI N/A
- EPS
- FGEN N/A
- WVVI N/A
- Revenue
- FGEN $180,015,000.00
- WVVI $39,259,016.00
- Revenue This Year
- FGEN $21.91
- WVVI N/A
- Revenue Next Year
- FGEN N/A
- WVVI N/A
- P/E Ratio
- FGEN N/A
- WVVI N/A
- Revenue Growth
- FGEN 16.15
- WVVI N/A
- 52 Week Low
- FGEN $0.18
- WVVI $3.17
- 52 Week High
- FGEN $2.80
- WVVI $6.33
- Technical
- Relative Strength Index (RSI)
- FGEN 65.95
- WVVI 65.31
- Support Level
- FGEN $0.54
- WVVI $5.70
- Resistance Level
- FGEN $0.88
- WVVI $6.20
- Average True Range (ATR)
- FGEN 0.07
- WVVI 0.34
- MACD
- FGEN 0.02
- WVVI -0.07
- Stochastic Oscillator
- FGEN 59.79
- WVVI 72.41
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.